Browsing by Author Rodriguez-Abreu, Delvys

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2017Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trialHui, Rina; Brahmer, Julie; Csoszi, Tibor; Cuffe, SinEad; Deitz, Anne; Fulop, Andrea; Gottfried, Maya; Hotta, Katsuyuki; Lubiniecki, Gregory; O'Brien, Mary; Peled, Nir; Rangwala, Reshma; Rao, Suman; Reck, Martin; Robinson, Andrew; Rodriguez-Abreu, Delvys; Tafreshi, Ali; Zhang, Jin; Westmead Clinical School: MedicineHealth-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial, The Lancet Oncology, vol.18, 12, 2017,pp 1600-1609
2018Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung CancerBoyer, Michael; Hui, Rina; Bischoff, Helge; Cheng, Susanna; Clingan, Philip R.; De Angelis, Flavia; Domine, Manuel; Esteban, Emilio; et al, Various; Felip, E; Gadgeel, Shirish; Gandhi, Leena; Garon, Edward; Grossi, Francesco; Hochmair, Maximilian; Jennens, Ross; Peled, Nir; Powell, Steen; Reck, M; Rodriguez-Abreu, Delvys; Rubio-Viqueira, Belen; Central Clinical School: Medicine; Westmead Clinical School: MedicinePembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer, New England Journal of Medicine, vol.378, 22, 2018,pp 2078-2092
2016Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung CancerHui, Rina; Csoszi, Tibor; Cuffe, SinEad; et al, Various; Fulop, Andrea; Gottfried, Maya; Peled, Nir; Reck, Martin; Robinson, Andrew; Rodriguez-Abreu, Delvys; Tafreshi, Ali; Western Clinical School: Medicine (Westmead)Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer, The New England Journal of Medicine, vol.375, 19, 2016,pp 1823-1833